XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share Based Compensation  
Schedule of outstanding and exercisable options

2022

Weighted

Number

average

of shares

exercise

    

2019 Plan

   

Inducement Plan

2011 Plan

   

Total

   

price

Outstanding at beginning of year - 2011 Plan

 

$

    

$

1,995,971

    

1,995,971

    

$

2.07

Outstanding at beginning of year - 2019 Plan

3,759,834

3,759,834

9.51

Granted - 2019 Plan

1,748,700

1,748,700

5.78

Granted - Inducement Plan

523,000

523,000

6.37

Expired - 2011 Plan

(1,121)

(1,121)

0.96

Exercised - 2011 Plan

(114,225)

(114,225)

1.38

Exercised - 2019 Plan

(15,089)

(15,089)

3.92

Forfeited - 2019 Plan

8.56

Cancelled - 2011 Plan

(19,387)

(19,387)

9.42

Cancelled - 2019 Plan

(17,950)

(17,950)

14.31

Outstanding at end of period

 

$

5,475,495

523,000

1,861,238

7,859,733

$

6.70

Outstanding at end of period - Weighted average exercise price

$

8.32

6.37

$

2.04

Exercisable at end of period

2,219,125

1,831,482

4,050,607

$

6.28

Exercisable at end of period - Weighted average exercise price

 

$

9.79

$

2.01

2021

Weighted

Number

average

of shares

exercise

2019 Plan

   

Inducement Plan

2011 Plan

   

Total

   

price

Outstanding at beginning of year - 2011 Plan

    

$

$

2,080,097

2,080,097

$

2.15

Outstanding at beginning of year - 2019 Plan

 

1,706,190

1,706,190

13.55

Granted - 2019 Plan

2,065,200

2,065,200

6.24

Forefeited - 2019 Plan

(13,882)

(13,882)

12.81

Cancelled - 2019 Plan

(1,167)

(1,167)

21.48

Exercised - 2011 Plan

(40,538)

(40,538)

0.97

Exercised - 2019 Plan

(1,250)

(1,250)

3.74

Outstanding at end of period

3,755,091

2,039,559

5,794,650

$

6.94

Outstanding at end of period - Weighted average exercise price

$

9.53

$

2.18

Exercisable at end of period

938,433

1,764,146

2,702,579

$

5.39

Exercisable at end of period - Weighted average exercise price

$

11.61

$

2.08

Schedule of non-vested share options activity

2022

Number

Weighted

of options

average

2019 Plan

    

Inducement Plan

    

2011 Plan

    

Total

    

fair value

Non-vested share options at beginning of year - 2011 Plan

    

 

200,639

200,639

 

$

1.86

Non-vested share options at beginning of year - 2019 Plan

2,665,518

2,665,518

 

6.39

Granted - 2019 Plan

 

1,748,700

1,748,700

4.37

Granted - Inducement Plan

523,000

523,000

4.81

Vested, outstanding 2011 Plan

(170,883)

(170,883)

 

1.76

Vested, outstanding 2019 Plan

(1,149,117)

(1,149,117)

5.99

Forfeited - 2019 Plan

(8,731)

(8,731)

6.27

Non-vested share options at end of period

 

3,256,370

523,000

29,756

3,809,126

 

$

5.34

Non-vested share options at end of period - Weighted average fair value

$

5.45

$

$

2.44

2021

Number

Weighted

of options

average

    

2019 Plan

    

Inducement Plan

    

2011 Plan

    

Total

    

fair value

Non-vested share options at beginning of year - 2011 Plan

 

543,192

543,192

 

$

1.81

Non-vested share options at beginning of year - 2019 Plan

1,438,026

1,438,026

 

10.28

Granted - 2019 Plan

 

2,065,200

2,065,200

4.71

Vested, outstanding 2011 Plan

(267,789)

(267,789)

 

1.64

Forfeited - 2019 Plan

(13,882)

(13,882)

9.18

Vested, outstanding 2019 Plan

(672,686)

(672,686)

9.17

Non-vested share options at end of period

 

2,816,658

275,403

3,092,061

 

$

6.07

Non-vested share options at end of period - Weighted average fair value

$

6.47

$

$

1.98

Schedule of weighted average assumptions for the options granted

Three months ended September 30, 

Nine months ended September 30, 

2022

    

2021

 

2022

    

2021

 

Exercise price

$

6.94

 

$

5.96

$

5.91

 

$

6.24

Share price

$

6.94

 

$

5.96

$

5.91

 

$

6.24

Volatility

 

93

%  

94

%

 

91

%  

94

%

Risk-free interest rate

 

2.94

%  

0.94

%

 

2.41

%  

1.04

%

Expected life

 

5.75

 

6.08

 

6.03

 

6.01

Dividend

 

0

%  

%

 

0

%  

0

%

Schedule of share-based compensation expense

Three months ended September 30, 

Nine months ended September 30, 

    

2022

    

2021

2022

    

2021

    

Administration

 

$

1,891

$

863

$

3,683

 

$

2,186

Research and development

 

349

821

2,302

 

2,226

Commercial activities

 

140

340

920

 

892

Total

 

$

2,380

$

2,024

$

6,905

 

$

5,304